Radiochemotherapy with amifostine cytoprotection for head and neck cancer

Supportive Care in Cancer

Volumn 6, Issue 2, 1998, Pages 155-160

  Büntzel, Jens ^a   Schuth, Julius ^b   Küttner, Klaus ^a   Glatzel, Michael ^a  

^a Klinikum Suhl   (Germany)

^b Essex Pharma GmbH   (Germany)

Author keywords

Amifostine; Head and neck cancer; Radiochemotherapy

Indexed keywords

AMIFOSTINE; ANALGESIC AGENT; ANTIBIOTIC AGENT; CARBOPLATIN; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PAIN; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NUTRITIONAL SUPPORT; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOPENIA; TREATMENT OUTCOME; XEROSTOMIA;

ADULT; AGED; AMIFOSTINE; ANTINEOPLASTIC AGENTS; CARBOPLATIN; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; RADIATION-PROTECTIVE AGENTS; TREATMENT OUTCOME;

EID: 0031888296     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005200050150     Document Type: Article

References (30)

1. Al-Sarraf M (1988) Head and neck cancer: chemotherapy concepts. Semin Oncol 15:70-85
2. American Cancer Society (1996) Cancer facts and figures - 1996. (Published data report) [Philadelphia]
3. Büntzel J, Glatzel M, Schuth J, Küttner K, Fröhlich D (1996) Einsatz von Amifostin bei simultaner Radio-Chemotherapie von HNO-Tumoren - eine Phase I/II Studie. Dtsch Z Onkol 28:42-49
4. Busch M, Schymura B, Hollenhorst H, Dühmke E (1996) Zytoprotektion mit Amifostin (Ethyol) in der Tumor-therapie. Strahlenther Onkol 172 [Suppl 1]:70
5. Dimery IW, Hong WK (1993) Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst 85:95-111
6. El-Sayed S, Nelson N (1996) Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: a meta-analysis of prospective and randomized trials. J Clin Oncol 14:838-847
7. Giglio R, Mickiewicz E, Pradier E, et al (1997) Alternating chemotherapy (CT) + radiotherapy (RT) with amifostine (A) protection for head and neck cancer (HN) Early stop of a randomized trial (abstract). Proc Am Soc Clin Oncol 16:384a
8. Grigsby P, Maruyama Y (1981) Modification of the oral radiation death syndrome with combined WR-2721 and misonidazole. Br J Radiol 54:969-972
9. Grigsby P, Maruyama Y (1982) Combined radiosensitization and radioprotection for oral cavity tumors: study with an oral cavity model. Int J Radiat Oncol Biol Phys 8:557-559
10. Landauer MR, Davis HD, Dominitz JA, Weiss JF (1988) Long-term effects of radioprotector WR-2721 on locomotor activity and body weight of mice following exposure to ionizing radiation. Toxicology 49:315-323
11. McDonald S, Meyerowitz C, Smudzin T, Rubin P (1994) Preliminary results of a pilot study using WR-2721 before fractionated irradiation of the head and neck to reduce salivary gland dysfunction. Int J Radiat Oncol Biol Phys 29:747-754
12. Merlano M, Vitale V, Rosso R, Benasso M, Corvò R, Cavallan M, et al (1992) Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 327:1115-1121
13. Merlano J, Benasso M, Corvò R, Rosso R, Vitale V, Blengio F, et al (1996) Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 88:583-589
14. Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47:207-214
15. Niibe H, Takahashi I, Mitsuhashi N, Miyaishi K, Itoh J, Maehara Y, Nakajima N, Suto H, Sakaino K, Matsuura S (1985) An evaluation of the clinical usefulness of amifostine (YM-08310), radioprotective agent. A double-blind placebo-controlled study. 1. Head and neck tumors (in Japanese). Nippon Can Chiryo Gakkai Shi 20:984-993
16. Panossian D, Jung TT, Weeks D, Sandefur J, Park YM, Miller SK, Krohn KA (1992) Effect of the radioprotector WR7221 on irradiation-induced injury to ciliated cells of eustachian tube. Ann Otol Rhinol Laryngol 101:395-402
17. Plantina AST, Vermorken JB, De Graeff A, Mulder PHM de, Jimeno J, Kwakkelstein MO (1994) Phase I/II dose escalation study of cisplatin with or without amifostine in patients with head and neck cancer. EORTC Head and Neck Center Cooperative Group Study 24911/ND 01921: results of the feasibility study. Ann Oncol 5 [Suppl 8]:119
18. Plantina AST, Vermerken JB, Catimel G, Mulder PHM de, De Graeff A, Oster W, Hoppener F (1996) Randomized phase II study of weekly cisplatin with or without anifostine in patients with advanced head and neck cancer. Proc Am Soc Clin Oncol 15:314
19. Pratt NE, Sodicoff M (1978) Morphological effects of WR-2721 on the rat parotid acinar cell. Radiat Res 75:327-335
20. Pratt NE, Sodicoff M, Liss M, Davis M, Sinesi M (1980) Radioprotection of the rat parotid gland by WR-2721: morphology at 60 days post-irradiation. Int J Radiat Oncol Biol Phys 6:431-435
21. Sodicoff M, Conger AD (1983) Radioprotection of the rat parotid gland by WR-2721 and isoproterenol and ist modification by popranolol. Radiat Res 94:97-104
22. Sodicoff M, Conger AD, Trepper P, Pratt NE (1978) Short-term radioprotective effects of WR-2721 on the rat parotid glands. Radiat Res 75:317-326
23. Sodicoff M, Conger AD, Pratt NE, Trepper P (1978) Radioprotection by WR-2721 against long-term chronic damage to the rat parotid gland. Radiat Res 76:172-179
24. Sodicoff M, Conger AD, Pratt NE (1979) Isoproterenol in comparison to WR-2721 as a chemoradioprotector of the rat parotid gland. Invest Radiol 14:166-170
25. Sodicoff M, Conger AD, Pratt NE, Sinesi M, Trepper P (1979) Chemoradioprotection of the rat parotid gland by combined use of WR-2721 an Ro-07-0582. Radiat Res 80:348-353
26. Takahashi I, Nagai T, Miyaishi K, Maehara Y, Niibe H (1986) Clinical study of the radioprotective effects of amifostine (YM-08310, WR-2721) on chronic radiation injury. Int J Radiat Oncol Biol Phys 12:935-938
27. Trog D, Füller J, Wendt T, Schuth J (1996) Reduktion gastrointestinaler Akuttoxizität unter Amifostingabe (Ethyol (R)) bei kombinierter Radio-Chemotherapie (RCT) lokal fortgeschrittener Tumoren im Kopf-Hals-Bereich (HNO). Strahlenther Onkol 172 [Suppl 1]:45
28. Utley JF, King R, Giansanti JS (1978) Radioprotection of oral cavity structures by WR-2721. Int J Radiat Oncol Biol Phys 4:643-647
29. Wibault P, Bensmaïne ME, Forni M de, Armand JP, Bemal ET, Guillot T, et al (1996) Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy iwth cisplatin and 7-week continuous infusional fluorouracil. J Clin Oncol 14:1192-1200
30. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK (1993) Medical progress: head and neck cancer. N Engl J Med 328:184-194